Pilot Study to Characterize the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of CLn® Skin Care Body Wash

Enrolling by invitation

Conditions studied: Cutaneous T Cell Lymphoma

In brief

In this pilot study of patients with mycosis fungoides, the most common form of CTCL, we propose to primarily evaluate the impact of daily use of the CLn Body Wash (dilute sodium hypochlorite (0.006% NaOCl)) on the microbiota of CTCL lesions. Should dilute sodium hypochlorite body wash improve the microbiome of MF, reducing the abundance of S. aureus, future, larger studies can more fully evaluate the impact on pruritus, erythema, scaling, disease evolution and its role in CTCL management.

Key facts

Study ID

NCT06665490

Run by

Northwestern University

People needed

15

Starts

2025-01-14

Expected to finish

2027-12-01

Last updated by the study team

2026-05-01

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults ages 18-89 years of age with active mycosis fungoides.
• Patients with concurrent and prior malignancies are allowed as long as any concurrent malignancy does not directly involve the same skin site.

You may not qualify if…

• Patients currently or recently (within past 4 weeks) on topical or systemic antibiotics, pregnant persons, or persons with potential of becoming pregnant or are/will be breastfeeding
• Patients that have initiated a new skin-directed therapy over the past month.

Where it is running

• Northwestern University Department of Dermatology — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.